Locomotor stimulant and discriminative stimulus effects of 'bath salt' cathinones

Behavioural Pharmacology

Volumn 24, Issue 5-6, 2013, Pages 437-447

  Gatch, Michael B ^a   Taylor, Cynthia M ^a   Forster, Michael J ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

abuse liability; cathinones; drug discrimination; locomotor activity; mouse; rat

Indexed keywords

4' METHYLMETHCATHINONE; CATHINONE; COCAINE; METHAMPHETAMINE; METHYLONE;

AMBULATORY CARE; ANIMAL EXPERIMENT; ANIMAL MODEL; BATH; COMPARATIVE STUDY; CONTROLLED STUDY; DISCRIMINATION LEARNING; DISCRIMINATIVE STIMULUS; EMERGENCY WARD; LOCOMOTION; MALE; MOUSE; NONHUMAN; RAT; REVIEW; SPRAGUE DAWLEY RAT;

ALKALOIDS; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHOICE BEHAVIOR; COCAINE; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; LOCOMOTION; MALE; MICE; RATS; RATS, SPRAGUE-DAWLEY; REGRESSION ANALYSIS; SELF ADMINISTRATION;

EID: 84881553576     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e328364166d     Document Type: Review

References (19)

1. Balster RL (1991). Drug abuse potential evaluation in animals. Br J Addict 86:1549-1558
2. Baumann MH, Ayestas MA Jr, Partilla JS, Sink JR, Shulgin AT, Daley PF, et al. (2012). The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology 37:1192-1203
3. Cozzi NV, Sievert MK, Shulgin AT, Pr Jacob, Ruoho AE (1999). Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines. Eur J Pharmacol 381:63-69
4. Dal Cason A, Young R, Glennon RA (1997). Cathinone: An investigation of several N-Alkyl and methylenedioxy-substituted analogs. Pharmacol Biochem Behav 58:1109-1116
5. Drug Enforcement Agency (2011). Request for information on synthetic cathinones. Microgram Bulletin 44:31-37, Available at: Http://www.justice-gov/ dea/pr/micrograms/2011/mg0411.pdf. [Accessed May 2013
6. Eshleman AJ, Wolfrum KM, Hatfield MG, Johnson RA, Murphy KV, Janowsky A (2013). Substituted methcathinones differ in transporter and receptor interactions. Biochem Pharmacol 85:1803-1815
7. Gatch MB, Forster MJ, Janowsky A, Eshleman AJ (2011). Abuse liability profile of three substituted tryptamines. J Pharmacol Exp Ther 338:280-289
8. Hadlock GC, Webb KM, McFadden LM, Chu PW, Ellis JD, Allen SC, et al. (2011). 4-Methylmethcathinone (mephedrone): Neuropharmacological effects of a designer stimulant of abuse. J Pharmacol Exp Ther 339:530-536
9. Huang PK, Aarde SM, Angrish D, Houseknecht KL, Dickerson TJ, Taffe MA (2012). Contrasting effects of d-methamphetamine, 3,4- methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats. Drug Alcohol Depend 126:168-175
10. Kehr J, Ichinose F, Yoshitake S, Goiny M, Sievertsson T, Nyberg F, Yoshitake T (2011). Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats. Br J Pharmacol 164:949-958
11. Lisek R, Xu W, Yuvasheva E, Chiu YT, Reitz AB, Liu-Chen LY, Rawls SM (2012). Mephedrone ('bath salt') elicits conditioned place preference and dopaminesensitive motor activation. Drug Alcohol Depend 126:257-262
12. López-Arnau R, Martínez-Clemente J, Pubill D, Escubedo E, Camarasa J (2012). Comparative neuropharmacology of three psychostimulant cathinone derivatives: Butylone, mephedrone and methylone. Br J Pharmacol 167:407-420
13. Martínez-Clemente J, Escubedo E, Pubill D, Camarasa J (2012). Interaction of mephedrone with dopamine and serotonin targets in rats. Eur Neuropsychopharmacol 22:231-236
14. Meltzer PC, Butler D, Deschamps JR, Madras BK (2006). 1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (pyrovalerone) analogues: A promising class of monoamine uptake inhibitors. J Med Chem 49:1420-1432
15. Motbey CP, Hunt GE, Bowen MT, Artiss S, McGregor IS (2012). Mephedrone (4-methylmethcathinone,'meow'): Acute behavioural effects and distribution of Fos expression in adolescent rats. Addict Biol 17:409-422
16. Nagai F, Nonaka R, Satoh K, Kamimura H (2007). The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 559:132-137
17. National Research Council (2003). Guidelines for the care and use of mammals in neuroscience and behavioral research. Washington, DC: The National Academies Press
18. National Drug Intelligence Center (2011). Situation report: Synthetic cathinones (bath salts): An emerging domestic threat. Product Number 2011-S0787-004. Johnstown, PA: National Drug Intelligence Center; Available at: Http:// www.justice.gov/archive/ndic/pubs44/44571/44571p.pdf
19. Spiller HA, Ryan ML,Weston RG, Jansen J (2011). Clinical experience with and analytical confirmation of ''bath salts'' and ''legal highs'' (synthetic cathinones) in the United States. Clin Toxicol 49:499-505